VIR Vir Biotechnology, Inc.
$11.60 -1.53%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
-1.53%
YTD
+104.90%
P/E
—
P/B
1.1
ROE
-14.9%
Div yield
—
Beta
1.73
Market cap
$1.9B
RSI (14)
60
Next earnings
Oct 29, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$11.90
Close
$11.60
VWAP (n/a)
—
Day high
$11.90
Day low
$11.26
Volume
2.6M
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Vir Biotechnology to Present Expanded Phase 2 SOLSTICE Results for Elebsiran and Tobevibart in Hepatitis Delta at AASLD’s The Liver Meeting® 2026
Yahoo Finance · Oct 5
Vir Biotechnology to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
Yahoo Finance · Aug 31
Vir Biotechnology (VIR) Q2 2026 Earnings Call Transcript
Yahoo Finance · Aug 12
Vir Biotechnology Inc (VIR) (Q2 2026) Earnings Call Highlights: 88% HDV Cure Rate and a $1B ...
Yahoo Finance · Aug 6
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2026 Financial Results
Yahoo Finance · Aug 5
Vir Biotechnology (VIR) Could Be 60% Undervalued On CFO Transition
Yahoo Finance · Aug 1
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Oct 1, 2026 View → 10-Q Aug 5, 2026 View → 8-K Aug 5, 2026 View → 8-K Jul 24, 2026 View → 8-K Jun 10, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell VIR. Try it in the Lab to size a position and see the risk.